Patents Assigned to Labopratoire Francais du Fractionnement et des Biotechnologies
  • Publication number: 20070218052
    Abstract: The invention relates to human or humanised, chimeric, monoclonal, class IgG3 antibodies produced in a cell line of rat myeloma, especially line YB2/0. Said antibodies have a strong phagocytosis activity and can be administered for the treatment of cancers and infections.
    Type: Application
    Filed: October 18, 2004
    Publication date: September 20, 2007
    Applicant: Labopratoire Francais du Fractionnement et des Biotechnologies
    Inventors: Christophe Romeuf, Sylvie Jorieux, Dominique Bourel, Philippe Klein, Nicolas Bihoreau